Achieve Life Sciences (ACHV) Times Interest Earned (2011 - 2018)
Achieve Life Sciences' (ACHV) quarterly Times Interest Earned came in at $0.92 in Q4 2018, up 106.5% YoY from $0.45 in Q4 2017, and up 171.82% on a QoQ basis from -$1.28 in Q3 2018.
Achieve Life Sciences (ACHV) Times Interest Earned (2011 - 2018) Analysis & Trends
Achieve Life Sciences (ACHV) has 6 years of Times Interest Earned data on file, last reported at $0.92 in Q4 2018.
- Quarterly Times Interest Earned rose 106.5% year-over-year to $0.92 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $0.82 (down 99.41% YoY) and the FY2019 annual result came in at -$92.15, down 12710.48% from the prior year.
- Times Interest Earned advanced to $0.92 in Q4 2018, from -$1.28 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.99 in Q1 2017 to a low of -$136.22 in Q4 2015.
- A 4-year average of -$17.2 and a median of -$2.17 in 2016 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 106.5% in 2018, down 213.93% in 2018.
- Tracing ACHV's Times Interest Earned over 4 years: stood at -$136.22 in 2015, then jumped by 90.95% to -$12.33 in 2016, then dropped by 15.23% to -$14.2 in 2017, then jumped by 106.5% to $0.92 in 2018.
- The last three Times Interest Earned figures came in at $0.92 (Q4 2018), -$1.28 (Q3 2018), and -$0.97 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.92 |
| Sep 30, 2018 | -1.28 |
| Jun 30, 2018 | -0.97 |
| Mar 31, 2018 | -1.13 |
| Dec 31, 2017 | -14.20 |
| Sep 30, 2017 | -4.73 |
| Mar 31, 2017 | 0.99 |
| Dec 31, 2016 | -12.33 |
| Sep 30, 2016 | -3.05 |
| Dec 31, 2015 | -136.22 |
| Dec 31, 2012 | 0.48 |
| Dec 31, 2011 | 1.30 |